Financial statements Clinical Trials Solutions

Balance sheet of Clinical Trials Solutions

Company age:
Age:
8 y. 25 d.
Share capital:
Share capital:
20 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of CLINICAL TRIALS SOLUTIONS

Year
2017
2019
2020
2021
2022
2023
Total assets 228 689,98 2 532 250,71 3 169 617,75 3 261 119,80 3 319 087,17 3 618 935,70
A. Fixed assets 0,00 8 959,50 1 416 823,67 2 091 469,43 8 519,05 2 540 802,76
B. Current assets 228 689,98 2 523 291,21 1 752 794,08 1 169 650,37 3 310 568,12 1 078 132,94
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 228 689,98 2 532 250,71 3 169 617,75 3 261 119,80 3 319 087,17 3 618 935,70
A. Equity 168 742,93 1 394 892,43 1 501 616,30 1 749 771,62 1 831 395,84 2 558 056,05
B. Liabilities and provisions for liabilities 59 947,05 1 137 358,28 1 668 001,45 1 511 348,18 1 487 691,33 1 060 879,65
I. Long-term liabilities 0,00 0,00 1 398 076,93 334 615,40 682 051,31 521 911,43
II. Short-term liabilities 59 947,05 1 137 358,28 269 924,52 1 176 732,78 805 640,02 538 968,22
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.